FDA Inspection 1313238 — Eunice S. Wang, M.D.
The FDA completed an inspection of Eunice S. Wang, M.D. on April 9, 2026 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Buffalo, NY (United States)
Additional Details
Clinical Investigator (CI)